Since its creation in 1875, Shimadzu has been a worldwide leading manufacturer of analytical instrumentation.
Our technologies are constantly driven by innovative thinking and new ideas, developing tools to deliver meaningful data and to help create better science. In the clinical research field, our mass spectrometry platforms in GC-MS, GC-MS/MS, LC-MS/MS and MALDI-TOF do more by bringing together robust, reliable detection together with UFMS (Ultra-Fast Mass Spectrometry) opening up new opportunities in identifying/quantifying more compunds with greater accuracy and certainty. At MSACL 2019 EU, we will show our technologies and workflows for clinical-based research including the new benchtop MALDI-8020. Visit our booth and attend our vendor seminar to discover all the benefits of UFMS technologies!